Publications: Prof Thomas Vulliamy
Savage SA, Bertuch AA, Ailments TTATCCCFT
(
2024
)
.
Different phenotypes with different endings—Telomere biology disorders and cancer predisposition with long telomeres
.
British Journal of Haematology
Tummala H, Walne AJ, Badat M, Patel M, Walne AM, Alnajar J, Chow CC, Albursan I et al.
(
2024
)
.
The evolving genetic landscape of telomere biology disorder dyskeratosis congenita
.
EMBO Molecular Medicine
vol.
16
,
(
10
)
2560
-
2582
.
Luzzatto L, Bancone G, Dugué P-A, Jiang W, Minucci A, Nannelli C, Pfeffer D, Prchal J et al.
(
2024
)
.
New WHO classification of genetic variants causing G6PD deficiency
.
Bulletin of the World Health Organization
vol.
102
,
(
8
)
615
-
617
.
Tummala H, Walne A, Buccafusca R, Alnajar J, Szabo A, Robinson P, McConkie-Rosell A, Wilson M et al.
(
2024
)
.
Germline thymidylate synthase deficiency impacts nucleotide metabolism and causes dyskeratosis congenita
.
American Journal of Human Genetics
vol.
111
,
(
7
)
Hakkarainen M, Kaaja I, Douglas SPM, Vulliamy T, Dokal I, Soulier J, Larcher L, Peffault de Latour R et al.
(
2023
)
.
The clinical picture of ERCC6L2 disease: from bone marrow failure to acute leukemia
.
Blood
vol.
141
,
(
23
)
2853
-
2866
.
Armes H, Bewicke‐Copley F, Rio‐Machin A, Di Bella D, Philippe C, Wozniak A, Tummala H, Wang J et al.
(
2022
)
.
Germline ERCC excision repair 6 like 2 (ERCC6L2) mutations lead to impaired erythropoiesis and reshaping of the bone marrow microenvironment
.
British Journal of Haematology
vol.
199
,
(
5
)
754
-
764
.
Feurstein S, Luo X, Shah M, Walker T, Mehta N, Wu D, Godley LA, Panel OBOTMMVCE
(
2022
)
.
Revision of RUNX1 variant curation rules
.
Blood Advances
vol.
6
,
(
16
)
4726
-
4730
.
Dokal I, Tummala H, Vulliamy T
(
2022
)
.
Inherited bone marrow failure in the pediatric patient
.
Blood
vol.
140
,
(
6
)
556
-
570
.
Tummala H, Walne A, Buccafusca R, Alnajar J, Szabo A, Robinson P, McConkie-Rosell A, Wilson M et al.
(
2022
)
.
Germline thymidylate synthase deficiency impacts nucleotide metabolism and causes dyskeratosis congenita
.
American Journal of Human Genetics
vol.
109
,
(
8
)
1472
-
1483
.
Armes H, Rio-Machin A, Krizsán S, Bödör C, Kaya F, Bewicke-Copley F, Alnajar J, Walne A et al.
(
2022
)
.
Acquired somatic variants in inherited myeloid malignancies
.
Leukemia
vol.
36
,
(
5
)
1377
-
1381
.
Armes H, Rio-Machin A, Krizsan S, Bodor C, Kaya F, Bewicke-Copley F, Alnajar J, Walne A et al.
(
2022
)
.
Acquired somatic variants in inherited myeloid malignancies
.
LEUKEMIA
vol.
36
,
(
5
)
1377
-
1381
.
Walne AJ, Vulliamy T, Bewicke-Copley F, Wang J, Alnajar J, Bridger MG, Ma B, Tummala H et al.
(
2021
)
.
Genome-wide whole-blood transcriptome profiling across inherited bone marrow failure subtypes
.
Blood Advances
vol.
5
,
(
23
)
5360
-
5371
.
Hakkarainen M, Douglas SPM, Vulliamy T, Dokal I, Soulier J, Larcher L, Niinimäki R, Siitonen T et al.
(
2021
)
.
Multinational Study on the Clinical and Genetic Features of the ERCC6L2-Disease
.
Blood
vol.
138
,
(
Supplement 1
)
Norris K, Walne AJ, Ponsford MJ, Cleal K, Grimstead JW, Ellison A, Alnajar J, Dokal I et al.
(
2021
)
.
High-throughput STELA provides a rapid test for the diagnosis of telomere biology disorders
.
Human Genetics
vol.
140
,
(
6
)
945
-
955
.
Dokal I, Tummala H, Vulliamy T, Walne A
(
2020
)
.
A frameshift variant in the specificity protein 1 triggers superactivation of SP1-mediated transcription in familial bone marrow failure
.
Proceedings of the National Academy of Sciences of USA
Article
32636268
,
Rio-Machin A, Vulliamy T, Hug N, Walne A, Tawana K, Cardoso S, Ellison A, Pontikos N et al.
(
2020
)
.
The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants
.
Nature Communications
vol.
11
,
(
1
)
Roper D, Layton M, Rees D, Lambert C, Vulliamy T, De la Salle B, D'Souza C, British Society for Haematology
(
2020
)
.
Laboratory diagnosis of G6PD deficiency. A British Society for Haematology Guideline
.
British Journal of Haematology
Luo X, Feurstein S, Mohan S, Porter CC, Jackson SA, Keel S, Chicka M, Brown AL et al.
(
2019
)
.
ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants
.
Blood Advances
vol.
3
,
(
20
)
2962
-
2979
.
Dokal I, Vulliamy T
(
2019
)
.
Germline NPM1 mutations lead to altered rRNA 2′-O-methylation and cause dyskeratosis congenita
.
Nature Genetics
vol.
51
,
1518
-
1529
.
Rio‐Machin A, Vulliamy T, Hug N, Caceres JF, Fitzgibbon J, Dokal I
(
2019
)
.
PF213 THE GENETIC LANDSCAPE OF FAMILIAL MDS/AML; RECURRING MUTATIONS IN THE RNA HELICASE DHX34 LEADING TO DEFECTS IN NONSENSE‐MEDIATED RNA DECAY
.
HemaSphere
vol.
3
,
(
S1
)
Brown AL, Armstrong M, Lawrence D, Wang P, Arts P, Duployez N, Churpek J, Tawana K et al.
(
2018
)
.
Development of a Data Portal for Aggregation and Analysis of Genomics Data in Familial Platelet Disorder with Predisposition to Myeloid Malignancy - the RUNX1.DB
.
Blood
vol.
132
,
(
Supplement 1
)
Godley L, Luo X, Ross J, Jackson S, Agarwal A, Baliakas P, Bertuch AA, Brown AL et al.
(
2018
)
.
Myeloid Malignancy Variant Curation Expert Panel: An ASH-Sponsored Clingen Expert Panel to Optimize and Validate Acmg/AMP Variant Interpretation Guidelines for Genes Associated with Inherited Myeloid Neoplasms
.
Blood
vol.
132
,
(
Supplement 1
)
DOKAL I, TUMMALA H, VULLIAMY T
(
2018
)
.
homozygous OB-fold variants in telomere protein TPP1 are associated with dyskeratosis congenita-like phenotypes
.
Blood
vol.
132
,
1349
-
1353
.
Tummala H, Dokal AD, Walne A, Ellison A, Cardoso S, Amirthasigamanipillai S, Kirwan M, Browne I et al.
(
2018
)
.
Genome instability is a consequence of transcription deficiency in patients with bone marrow failure harboring biallelic ERCC6L2 variants
.
Proc Natl Acad Sci U S A
vol.
115
,
(
30
)
7777
-
7782
.
Laffan MA, Vulliamy T, Schmitz E, Swisky D
(
2018
)
.
Factor V Leiden and Sickle Cell Disease
.
Thrombosis and Haemostasis
vol.
75
,
(
05
)
859
-
860
.
Al Seraihi AF, Rio-Machin A, Tawana K, Bödör C, Wang J, Nagano A, Heward JA, Iqbal S et al.
(
2018
)
.
GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS/AML
.
Leukemia
vol.
32
,
(
11
)
2502
-
2507
.
Walne A, Tummala H, Ellison A, Cardoso S, Sidhu J, Sciuccati G, Vulliamy T, Dokal I
(
2018
)
.
Expanding the phenotypic and genetic spectrum of radioulnar synostosis associated hematological disease
.
Haematologica
vol.
103
,
(
7
)
e284
-
e287
.
Al Seraihi AF, Rio-Machin A, Tawana K, Bodor C, Wang J, Nagano A, Heward JA, Iqbal S et al.
(
2018
)
.
<i>GATA2</i> monoallelic expression underlies reduced penetrance in inherited <i>GATA2</i>-mutated MDS/AML
.
LEUKEMIA
vol.
32
,
(
11
)
2502
-
2507
.
Krishnamoorthy R, Ahouignan G, Laffan M, Rahimy M, Vulliamy T
(
2017
)
.
The 20210A Allele of Prothrombin Is not Found among Sickle Cell Disease Patients from West Africa
.
Thrombosis and Haemostasis
vol.
79
,
(
02
)
444
-
445
.
Cardoso SR, Ellison ACM, Walne AJ, Cassiman D, Raghavan M, Kishore B, Ancliff P, Rodríguez-Vigil C et al.
(
2017
)
.
Myelodysplasia and liver disease extend the spectrum of RTEL1 related telomeropathies
.
Haematologica
vol.
102
,
(
8
)
e293
-
e296
.
Pontikos N, Yu J, Moghul I, Withington L, Blanco-Kelly F, Vulliamy T, Wong TLE, Murphy C et al.
(
2017
)
.
Phenopolis: An open platform for harmonization and analysis of genetic and phenotypic data
.
Bioinformatics
vol.
33
,
(
15
)
2421
-
2423
.
GRIGG JM
(
2016
)
.
Urinary prostanoids in preschool wheeze
.
European Respiratory Journal
Al Seraihi A, Rio-Machin A, Tawana K, Bödör C, Araf S, Heward JA, Smith M, Iqbal S et al.
(
2016
)
.
Variable Penetrance Is Linked with Monoallelic Gene Expression in Inherited GATA2-Mutated MDS/AML
.
Blood
.
vol.
128
,
Köhler S, Vasilevsky NA, Engelstad M, Foster E, McMurry J, Aymé S, Baynam G, Bello SM et al.
(
2016
)
.
The Human Phenotype Ontology in 2017
.
Nucleic Acids Research
vol.
45
,
(
D1
)
d865
-
d876
.
Pontikos N, Yu J, Blanco-Kelly F, Vulliamy T, Wong TL, Murphy C, Cipriani V, Fiorentino A et al.
(
2016
)
.
Phenopolis: an open platform for harmonization and analysis of sequencing and phenotype data
.
Walne AJ, Collopy L, Cardoso S, Ellison A, Plagnol V, Albayrak C, Albayrak D, Kilic SS et al.
(
2016
)
.
Marked overlap of four genetic syndromes with dyskeratosis congenita confounds clinical diagnosis
.
Haematologica
vol.
101
,
(
10
)
1180
-
1189
.
Walton RT, Mudway IS, Dundas I, Marlin N, Koh LC, Aitlhadj L, Vulliamy T, Jamaludin JB et al.
(
2016
)
.
Air pollution, ethnicity and telomere length in east London schoolchildren: An observational study
.
Environment International
vol.
96
,
41
-
47
.
Tummala H, Walne AJ, Williams M, Bockett N, Collopy L, Cardoso S, Ellison A, Wynn R et al.
(
2016
)
.
DNAJC21 Mutations Link a Cancer-Prone Bone Marrow Failure Syndrome to Corruption in 60S Ribosome Subunit Maturation
.
American Journal of Human Genetics
vol.
99
,
(
1
)
115
-
124
.
Sbarrato T, Horvilleur E, Pöyry T, Hill K, Chaplin LC, Spriggs RV, Stoneley M, Wilson L et al.
(
2016
)
.
A ribosome-related signature in peripheral blood CLL B cells is linked to reduced survival following treatment
.
Cell Death and Disease
vol.
7
,
(
6
)
e2249
-
e2249
.
DOKAL I
(
2016
)
.
Germline heterozygous DDX41 vriants in a subset of familial myelodysplasia and acute myeloid leukaemia
.
Leukemia
Suraweera N, Mouradov D, Li S, Jorissen RN, Hampson D, Ghosh A, Sengupta N, THAHA MA et al.
(
2016
)
.
Relative telomere lengths in tumor and normal mucosa are related to disease progression and chromosome instability profiles in colorectal cancer
.
Oncotarget
Collins J, Tummala H, Collopy L, Vulliamy T, Dokal I
(
2016
)
.
In-vitro analysis of the effects of TA65 and danazol on the proliferation and telomerase activity of T lymphocytes in bone marrow failure syndromes
.
The Lancet
.
vol.
387
,
Vulliamy T, Kaeda J, Foroni L, Bain BJ
(
2016
)
.
Molecular and cytogenetic analysis
.
Dacie and Lewis Practical Haematology, Eleventh Edition
,
Nwokoro C, Pandya H, Turner S, Eldridge S, Griffiths CJ, Vulliamy T, Price D, Sanak M et al.
(
2015
)
.
Parent-determined oral montelukast therapy for preschool wheeze with stratification for arachidonate-5-lipoxygenase (ALOX5) promoter genotype
.
Efficacy and Mechanism Evaluation
vol.
2
,
(
6
)
1
-
126
.
Collopy LC, Walne AJ, Cardoso S, de la Fuente J, Mohamed M, Toriello H, Tamary H, Ling AJYV et al.
(
2015
)
.
Triallelic and epigenetic-like inheritance in human disorders of telomerase
.
Blood
vol.
126
,
(
2
)
176
-
184
.
Tummala H, Walne A, Collopy L, Cardoso S, de la Fuente J, Lawson S, Powell J, Cooper N et al.
(
2015
)
.
Poly(A)-specific ribonuclease deficiency impacts telomere biology and causes dyskeratosis congenita
.
Journal of Clinical Investigation
vol.
125
,
(
5
)
2151
-
2160
.
Boufleur K, Scrideli CA, Valera E, Tone L, Vulliamy T, Arruda LK, Roxo P
(
2015
)
.
DKC1 mutation causing different phenotypes in a family with X-linked Hoyeraal-Hreidarsson syndrome
.
World Allergy Organization Journal
vol.
8
,
(
Suppl 1
)
Dokal I, Vulliamy T, Mason P, Bessler M
(
2015
)
.
Clinical utility gene card for: Dyskeratosis congenita - update 2015
.
EUROPEAN JOURNAL OF HUMAN GENETICS
vol.
23
,
(
4
)
Nwokoro C, Pandya H, Turner S, Eldridge S, Griffiths CJ, Vulliamy T, Price D, Sanak M et al.
(
2014
)
.
Intermittent montelukast in children aged 10 months to 5 years with wheeze (WAIT trial): a multicentre, randomised, placebo-controlled trial
.
Lancet Respir Med
vol.
2
,
(
10
)
796
-
803
.
Dokal I, Vulliamy T, Mason P, Bessler M
(
2014
)
.
Clinical utility gene card for: Dyskeratosis congenita
.
European Journal of Human Genetics
Collopy LC, Walne AJ, Vulliamy TJ, Dokal IS
(
2014
)
.
Targeted resequencing of 52 bone marrow failure genes in patients with aplastic anemia reveals an increased frequency of novel variants of unknown significance only in SLX4
.
Haematologica
vol.
99
,
(
7
)
e109
-
e111
.
Tummala H, Kirwan M, Walne AJ, Hossain U, Jackson N, Pondarre C, Plagnol V, Vulliamy T et al.
(
2014
)
.
ERCC6L2 mutations link a distinct bone-marrow-failure syndrome to DNA repair and mitochondrial function
.
Am J Hum Genet
vol.
94
,
(
2
)
246
-
256
.
Drašar ER, Jiang J, Gardner K, Howard J, Vulliamy T, Vasavda N, Thein SL
(
2014
)
.
Leucocyte telomere length in patients with sickle cell disease
.
British Journal of Haematology
vol.
165
,
(
5
)
725
-
727
.
Drasar E, Jiang J, Gardner K, Howard J, Vulliamy T, Vasavda N, Thein SL
(
2013
)
.
Telomere Lengths Correlate With Inflammatory Markers In Sickle Cell Disease
.
Blood
.
vol.
122
,
Islam A, Rafiq S, Kirwan M, Walne A, Cavenagh J, Vulliamy T, Dokal I
(
2013
)
.
Haematological recovery in dyskeratosis congenita patients treated with danazol
.
Br J Haematol
vol.
162
,
(
6
)
854
-
856
.
lvis TV, María SB, Sabrine TF, Pérsio RJ, Barbara L-S, Tom V, Rodrigo TC, Carlos AS et al.
(
2013
)
.
Does <i>DKC</i>1 Mutation Suffice to Define the Phenotype Severity of Hoyeraal-Hreidarsson Syndrome?
.
Open Journal of Blood Diseases
vol.
03
,
(
01
)
57
-
61
.
Walne AJ, Vulliamy T, Kirwan M, Plagnol V, Dokal I
(
2013
)
.
Constitutional mutations in RTEL1 cause severe dyskeratosis congenita
.
Am J Hum Genet
vol.
92
,
(
3
)
448
-
453
.
Walne AJ, Bhagat T, Kirwan M, Gitiaux C, Desguerre I, Leonard N, Nogales E, Vulliamy T et al.
(
2013
)
.
Mutations in the telomere capping complex in bone marrow failure and related syndromes
.
Haematologica
vol.
98
,
(
3
)
334
-
338
.
Koh LC, Kelly FJ, Griffiths C, Dundas I, Wood HE, Jamaludin JB, Mudway IS, Walton R et al.
(
2013
)
.
Telomere length and lung function in healthy children
.
EUROPEAN RESPIRATORY JOURNAL
vol.
42
,
Aslan D, Akata RF, Holme H, Vulliamy T, Dokal I
(
2012
)
.
Limbal stem cell deficiency in patients with inherited stem cell disorder of dyskeratosis congenita
.
Int Ophthalmol
vol.
32
,
(
6
)
615
-
622
.
Gleeson M, O'Marcaigh A, Cotter M, Brosnahan D, Vulliamy T, Smith OP
(
2012
)
.
Retinal vasculopathy in autosomal dominant dyskeratosis congenita due to TINF2 mutation
.
Br J Haematol
vol.
159
,
(
5
)
Holme H, Hossain U, Kirwan M, Walne A, Vulliamy T, Dokal I
(
2012
)
.
Marked genetic heterogeneity in familial myelodysplasia/acute myeloid leukaemia
.
Br J Haematol
vol.
158
,
(
2
)
242
-
248
.
Kirwan M, Walne AJ, Plagnol V, Velangi M, Ho A, Hossain U, Vulliamy T, Dokal I
(
2012
)
.
Exome sequencing identifies autosomal-dominant SRP72 mutations associated with familial aplasia and myelodysplasia
.
Am J Hum Genet
vol.
90
,
(
5
)
888
-
892
.
Walne AJ, Dokal A, Plagnol V, Beswick R, Kirwan M, de la Fuente J, Vulliamy T, Dokal I
(
2012
)
.
Exome sequencing identifies MPL as a causative gene in familial aplastic anemia
.
Haematologica
vol.
97
,
(
4
)
524
-
528
.
Jongmans MCJ, Verwiel ETP, Heijdra Y, Vulliamy T, Kamping EJ, Hehir-Kwa JY, Bongers EMHF, Pfundt R et al.
(
2012
)
.
Revertant somatic mosaicism by mitotic recombination in dyskeratosis congenita
.
Am J Hum Genet
vol.
90
,
(
3
)
426
-
433
.
Vulliamy T, Kaeda J, Foroni L, Bain BJ
(
2012
)
.
Chapter 8 Molecular and cytogenetic analysis
.
Dacie and Lewis Practical Haematology
,
Elsevier
Lescai F, Bonfiglio S, Bacchelli C, Chanudet E, Waters A, Sisodiya SM, Kasperavičiūtė D, Williams J et al.
(
2012
)
.
Characterisation and validation of insertions and deletions in 173 patient exomes
.
PLoS One
vol.
7
,
(
12
)
Vulliamy T, Beswick R, Kirwan MJ, Hossain U, Walne AJ, Dokal I
(
2012
)
.
Telomere length measurement can distinguish pathogenic from non-pathogenic variants in the shelterin component, TIN2
.
Clin Genet
vol.
81
,
(
1
)
76
-
81
.
Dokal I, Vulliamy T, Mason P, Bessler M
(
2011
)
.
Clinical utility gene card for: dyskeratosis congenita
.
Eur J Hum Genet
vol.
19
,
(
11
)
Blaydon DC, Biancheri P, Di W-L, Plagnol V, Cabral RM, Brooke MA, van Heel DA, Ruschendorf F et al.
(
2011
)
.
Inflammatory skin and bowel disease linked to ADAM17 deletion
.
N Engl J Med
vol.
365
,
(
16
)
1502
-
1508
.
Kirwan M, Beswick R, Walne AJ, Hossain U, Casimir C, Vulliamy T, Dokal I
(
2011
)
.
Dyskeratosis congenita and the DNA damage response
.
Br J Haematol
vol.
153
,
(
5
)
634
-
643
.
Blaydon DC, Walne AJ, Plagnol V, van Heel DA, Vulliamy T, Kelsell DP
(
2011
)
.
Using next-generation sequencing to identify novel disease genes
.
BRITISH JOURNAL OF DERMATOLOGY
.
vol.
164
,
930
-
931
.
Vulliamy TJ, Kirwan MJ, Beswick R, Hossain U, Baqai C, Ratcliffe A, Marsh J, Walne A et al.
(
2011
)
.
Differences in disease severity but similar telomere lengths in genetic subgroups of patients with telomerase and shelterin mutations
.
PLoS One
vol.
6
,
(
9
)
Walne AJ, Vulliamy T, Beswick R, Kirwan M, Dokal I
(
2010
)
.
Mutations in C16orf57 and normal-length telomeres unify a subset of patients with dyskeratosis congenita, poikiloderma with neutropenia and Rothmund-Thomson syndrome
.
Hum Mol Genet
vol.
19
,
(
22
)
4453
-
4461
.
Jaganathan BG, Tisato V, Vulliamy T, Dokal I, Marsh J, Dazzi F, Bonnet D
(
2010
)
.
Effects of MSC co-injection on the reconstitution of aplastic anemia patient following hematopoietic stem cell transplantation
.
Leukemia
vol.
24
,
(
10
)
1791
-
1795
.
Mortazavi Y, Mirzamohammadi F, Ardestani MT, Mirimoghadam E, Vulliamy TJ
(
2010
)
.
Glucos 6-phosphate dehydrogenase deficiency in Tehran, Zanjan and sistan-balouchestan provinces: Prevalence and frequency of Mediterranean variant of G6PD
.
Iranian Journal of Biotechnology
vol.
8
,
(
4
)
229
-
233
.
Mason PJ, Vulliamy TJ
(
2010
)
.
Glucose‐6‐phosphate Dehydrogenase (G6PD) Deficiency: Genetics
.
Encyclopedia of Life Sciences
,
Wiley
Mansour S, Connell F, Steward C, Ostergaard P, Brice G, Smithson S, Lunt P, Jeffery S et al.
(
2010
)
.
Emberger sndrome - Primary lymphedema with myelodysplasia: Report of seven new cases
.
American Journal of Medical Genetics, Part A
vol.
152
,
(
9
)
2287
-
2296
.
Mansour S, Connell F, Steward C, Ostergaard P, Brice G, Smithson S, Lunt P, Jeffery S et al.
(
2010
)
.
Emberger syndrome-primary lymphedema with myelodysplasia: report of seven new cases
.
Am J Med Genet A
vol.
152A
,
(
9
)
2287
-
2296
.
Dokal I, Vulliamy T
(
2010
)
.
Inherited bone marrow failure syndromes
.
Haematologica
vol.
95
,
(
8
)
1236
-
1240
.
Valera ET, Brassesco MS, Roxo P, Lourenço CM, Scrideli CA, Ferriani VP, Tone LG, Vulliamy T et al.
(
2010
)
.
Genomic instability in Hoyeraal-Hreidarsson syndrome
.
Pediatr Blood Cancer
vol.
54
,
(
5
)
779
-
780
.
Vuong LG, Hemmati PG, Neuburger S, Terwey TH, Vulliamy T, Dokal I, le Coutre P, Dörken B et al.
(
2010
)
.
Reduced-intensity conditioning using fludarabine and antithymocyte globulin alone allows stable engraftment in a patient with dyskeratosis congenita
.
Acta Haematol
vol.
124
,
(
4
)
200
-
203
.
Ashbridge B, Orte A, Yeoman JA, Kirwan M, Vulliamy T, Dokal I, Klenerman D, Balasubramanian S
(
2009
)
.
Single-molecule analysis of the human telomerase RNA.dyskerin interaction and the effect of dyskeratosis congenita mutations
.
Biochemistry
vol.
48
,
(
46
)
10858
-
10865
.
Kirwan M, Vulliamy T, Marrone A, Walne AJ, Beswick R, Hillmen P, Kelly R, Stewart A et al.
(
2009
)
.
Defining the pathogenic role of telomerase mutations in myelodysplastic syndrome and acute myeloid leukemia
.
Hum Mutat
vol.
30
,
(
11
)
1567
-
1573
.
Vulliamy TJ
(
2009
)
.
Premature aging
.
Cell Mol Life Sci
vol.
66
,
(
18
)
3091
-
3094
.
Borggraefe I, Koletzko S, Arenz T, Fuehrer M, Hoffmann F, Dokal I, Vulliamy T, Weiler V et al.
(
2009
)
.
Severe variant of x-linked dyskeratosis congenita (Hoyeraal-Hreidarsson Syndrome) causes significant enterocolitis in early infancy
.
J Pediatr Gastroenterol Nutr
vol.
49
,
(
3
)
359
-
363
.
Scott CS, Vulliamy T, Catcevsky D, Matutes E, Norfolk DR
(
2009
)
.
DNA Genotypic Conservation During Phenotypic Switch from T-cell Acute Lymphoblastic Leukaemia to Acute Myeloblastic Leukaemia
.
Leukemia & Lymphoma
vol.
1
,
(
1
)
21
-
28
.
McMullin MF, Chapple M, Vulliamy T, Adams J, Gordon A, Swirsky DM, Barrett AJ, Thorpe PA et al.
(
2009
)
.
Systemic Mastocytosis with an Abnormally Expanded T-Cell Clone
.
Leukemia & Lymphoma
vol.
6
,
(
4-5
)
419
-
422
.
Walne J, Vulliamy T, Beswick R, Kirwan M, Dokal I
(
2009
)
.
GENETIC ANALYSIS OF THE SHELTERIN COMPLEX COMPONENTS (POT1 RAP1, TPP1, TRF1 AND TRF2) IN DYSKERATOSIS CONGENITA
.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL
.
vol.
94
,
236
-
236
.
Balci S, Engiz O, Erekul A, Gozdasoglu S, Vulliamy T
(
2009
)
.
An atypical form of dyskeratosis congenita with renal agenesis and no mutation in DKC1, TERC and TERT genes
.
J Eur Acad Dermatol Venereol
vol.
23
,
(
5
)
607
-
608
.
Bashey A, Vulliamy T, Cai BS, Schwarer AP, Goldman JM
(
2009
)
.
Non‐lymphoid blast crisis of CML with rearrangement of immunoglobulin and T‐cell receptor delta genes
.
European Journal Of Haematology
vol.
47
,
(
1
)
36
-
41
.
Kirwan M, Beswick R, Vulliamy T, Nathwani AC, Walne AJ, Casimir C, Dokal I
(
2009
)
.
Exogenous TERC alone can enhance proliferative potential, telomerase activity and telomere length in lymphocytes from dyskeratosis congenita patients
.
Br J Haematol
vol.
144
,
(
5
)
771
-
781
.
Kirwan M, Vulliamy T, Walne AJ, Beswick R, Hillmen P, Kelly R, Stewart A, Bowen D et al.
(
2008
)
.
Defective Telomerase in Familial Myelodysplasia and Leukemia
.
BLOOD
.
vol.
112
,
314
-
314
.
de la Fuente J, O'Boyle F, Killeen N, Tso A, New H, Atra A, Dokal I, Vulliamy T et al.
(
2008
)
.
Low Dose Alemtuzumab Achieves Long-Term Engraftment with Low Level Mixed Chimerism in Related Haemopoietic Stem Cell Transplantation for Haemoglobinopathies
.
Blood
vol.
112
,
(
11
)
De La Fuente J, O'Boyle F, Killeen N, Tso A, New H, Atra A, Dokal I, Vulliamy T et al.
(
2008
)
.
Low Dose Alemtuzumab Achieves Long-Term Engraftment with Low Level Mixed Chimerism in Related Haemopoietic Stem Cell Transplantation for Haemoglobinopathies
.
BLOOD
.
vol.
112
,
1135
-
1135
.
Walne AJ, Vulliamy T, Beswick R, Kirwan M, Dokal I
(
2008
)
.
TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes
.
Blood
vol.
112
,
(
9
)
3594
-
3600
.
Bayoumi RA, Nur-E-Kamal MSA, Tadayyon M, Mohamed KKA, Mahboob BH, Qureshi MM, Lakhani MS, Awaad MO et al.
(
2008
)
.
Molecular Characterization of Erythrocyte Glucose-6-Phosphate Dehydrogenase Deficiency in Al-Ain District, United Arab Emirates
.
Human Heredity
vol.
46
,
(
3
)
136
-
141
.
Daar S, Vulliamy TJ, Kaeda J, Mason PJ, Luzzatto L
(
2008
)
.
Molecular Characterization of G6PD Deficiency in Oman
.
Human Heredity
vol.
46
,
(
3
)
172
-
176
.
Balci S, Engiz O, Erekul A, Gozdasoglu S, Vulliamy T
(
2008
)
.
An atypical form of dyskeratosis congenita with renal agenesis and no mutation in DKC1, TERC and TERT genes
.
J Eur Acad Dermatol Venereol
Vulliamy T, Beswick R, Kirwan M, Marrone A, Digweed M, Walne A, Dokal I
(
2008
)
.
Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita
.
Proc Natl Acad Sci U S A
vol.
105
,
(
23
)
8073
-
8078
.
Walne J, Vulliamy T, Beswick R, Kirwan M, Dokal I
(
2008
)
.
CHARACTERISATION OF TINF2 MUTATIONS IN A LARGE COHORT OF PATIENTS WITH DYSKERATOSIS CONGENITA AND RELATED BONE MARROW FAILURE SYNDROMES
.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL
.
vol.
93
,
188
-
188
.
Basel-Vanagaite L, Dokal I, Tamary H, Avigdor A, Garty BZ, Volkov A, Vulliamy T
(
2008
)
.
Expanding the clinical phenotype of autosomal dominant dyskeratosis congenita caused by TERT mutations
.
Haematologica
vol.
93
,
(
6
)
943
-
944
.
Dokal I, Vulliamy T
(
2008
)
.
Inherited aplastic anaemias/bone marrow failure syndromes
.
Blood Rev
vol.
22
,
(
3
)
141
-
153
.
Walne AJ, Marrone A, Beswick R, Kirwan M, Dokal I, Vulliamy T
(
2008
)
.
Analysis of the RECQL4 helicase gene in patients with dyskeratosis congenita
.
BRITISH JOURNAL OF HAEMATOLOGY
.
vol.
141
,
63
-
63
.
Macdonald D, Jiang YZ, Swirsky D, Vulliamy T, Morilla R, Bungey And J, Barrett AJ
(
2008
)
.
Acute myeloid leukaemia relapsing following interleukin‐2 treatment expresses the alpha chain of the interleukin‐2 receptor
.
British Journal of Haematology
vol.
77
,
(
1
)
43
-
49
.
Kaeda JS, Prasad K, Howard RJ, Mehta A, Vulliamy T, Luzzatto L
(
2008
)
.
Management of pregnancy when maternal blood has a very high level of fetal haemoglobin
.
British Journal of Haematology
vol.
88
,
(
2
)
432
-
434
.
Rovira A, Vulliamy T, Pujades MA, Luzzatto L, Vives JL
(
2008
)
.
Molecular genetics of glucose‐6‐phosphate dehydrogenase (G6PD) deficiency in Spain: identification of two new point mutations in the G6PD gene
.
British Journal of Haematology
vol.
91
,
(
1
)
66
-
71
.
Kirwan M, Vulliamy T, Beswick R, Walne AJ, Casimir C, Dokal I
(
2008
)
.
Circulating haematopoietic progenitors are differentially reduced amongst subtypes of dyskeratosis congenita
.
Br J Haematol
vol.
140
,
(
6
)
719
-
722
.
Vulliamy T, Kaeda J, de CLC, Bain BJ
(
2008
)
.
21 Análisis molecular y citogenético
.
Dacie y Lewis. Hematología Práctica
,
Elsevier
Bain BJ, Bates I, Blackmore S, Bradshaw A, Catovsky D, De la Salle B, Dokal I, Hamilton M et al.
(
2008
)
.
Autores
.
Dacie y Lewis. Hematología Práctica
,
Elsevier
Vulliamy TJ, Dokal I
(
2008
)
.
Dyskeratosis congenita: the diverse clinical presentation of mutations in the telomerase complex
.
Biochimie
vol.
90
,
(
1
)
122
-
130
.
Marrone A, Walne A, Tamary H, Masunari Y, Kirwan M, Beswick R, Vulliamy T, Dokal I
(
2007
)
.
Telomerase reverse-transcriptase homozygous mutations in autosomal recessive dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome
.
Blood
vol.
110
,
(
13
)
4198
-
4205
.
MEHTA AB, VULLIAMY T, GORDON‐SMITH EC, LUZZATTO L
(
2007
)
.
A new genetic polymorphism in the 16S ribosomal RNA gene of human motochondrial DNA
.
Annals of Human Genetics
vol.
53
,
(
4
)
303
-
310
.
Marrone A, Sokhal P, Walne A, Beswick R, Kirwan M, Killick S, Williams M, Marsh J et al.
(
2007
)
.
Functional characterization of novel telomerase RNA (TERC) mutations in patients with diverse clinical and pathological presentations
.
Haematologica
vol.
92
,
(
8
)
1013
-
1020
.
Walne AJ, Vulliamy T, Marrone A, Beswick R, Kirwan M, Masunari Y, Al-Qurashi F-H, Aljurf M et al.
(
2007
)
.
Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10
.
Hum Mol Genet
vol.
16
,
(
13
)
1619
-
1629
.
Marrone A, Vulliamy T, Walne A, Dokal I
(
2007
)
.
Functional characterisation of mutations in the telomerase complex: no evidence of a dominant negative effect
.
BRITISH JOURNAL OF HAEMATOLOGY
.
vol.
137
,
4
-
5
.
Walne AJ, Vulliamy TJ, Marrone A, Beswick R, Kirwan MJ, Masunari Y, Al-Qurashi F, Aljurf M et al.
(
2007
)
.
The telomerase-associated protein NOP10 is mutated in autosomal recessive dyskeratosis congenita
.
BRITISH JOURNAL OF HAEMATOLOGY
.
vol.
137
,
80
-
80
.
Beutler E, Duparc S, Doumbo O, Ghosh K, De Lacerda MVG, Lapierre D, Looareesuwan S, Premji Z et al.
(
2007
)
.
Glucose-6-phosphate dehydrogenase deficiency and antimalarial drug development
.
American Journal of Tropical Medicine and Hygiene
vol.
77
,
(
4
)
779
-
789
.
Vulliamy T, Kaeda J
(
2006
)
.
Molecular and cytogenetic analysis
.
555
-
594
.
Halsey C, Ndoni SA, Babaei-Jadidi R, Roper D, Wild BJ, Vulliamy TJ, Thornalley PJ, Layton M
(
2006
)
.
A Novel Therapeutic Approach in Triosephosphate Isomerase Deficiency
.
Blood
vol.
108
,
(
11
)
Ndoni SA, Babaei-Jadidi R, Roper D, Wild BJ, Vulliamy TJ, Thornalley PJ, Layton M
(
2006
)
.
A novel therapeutic approach in triosephosphate isomerase deficiency
.
BLOOD
.
vol.
108
,
7B
-
7B
.
Vulliamy T, Dokal I
(
2006
)
.
Dyskeratosis congenita
.
Semin Hematol
vol.
43
,
(
3
)
157
-
166
.
Walne A, Vulliamy T, Marrone A, Dokal I
(
2006
)
.
Genetic heterogeneity exists in autosomal recessive Dyskeratosis congenita
.
BRITISH JOURNAL OF HAEMATOLOGY
.
vol.
133
,
76
-
76
.
Vulliamy TJ
(
2006
)
.
Invited lecture: The pathogenesis of dyskeratosis congenita: New insights into the causes of bone marrow failure
.
Leukemia Research
vol.
30
,
Vulliamy TJ, Marrone A, Knight SW, Walne A, Mason PJ, Dokal I
(
2006
)
.
Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation
.
Blood
vol.
107
,
(
7
)
2680
-
2685
.
Vulliamy TJ, Walne A, Marrone A, Kratz C, Dokal I
(
2006
)
.
Mutations in the reverse transcriptase component of telomerase: their impact on telomere length and bone marrow failure
.
BRITISH JOURNAL OF HAEMATOLOGY
.
vol.
133
,
32
-
32
.
De Araujo C, Migot-Nabias F, Guitard J, Pelleau S, Vulliamy T, Ducrocq R
(
2006
)
.
The role of the G6PD AEth376G/968C allele in glucose-6-phosphate dehydrogenase deficiency in the seerer population of Senegal
.
Haematologica
vol.
91
,
(
2
)
262
-
263
.
Mason PJ, Vulliamy TJ
(
2006
)
.
Glucose‐6‐Phosphate Dehydrogenase (G6PD) Deficiency: Genetics
.
Encyclopedia of Life Sciences
,
Wiley
Vulliamy T, Kaeda J, Bain WCFB
(
2006
)
.
Chapter 21 Molecular and cytogenetic analysis
.
Dacie and Lewis Practical Haematology
,
Elsevier
Percy MJ, Crowley LJ, Roper D, Vulliamy TJ, Layton DM, Barber MJ
(
2006
)
.
Identification and characterization of the novel FAD-binding lobe G75S mutation in cytochrome b(5) reductase: an aid to determine recessive congenital methemoglobinemia status in an infant
.
Blood Cells Mol Dis
vol.
36
,
(
1
)
81
-
90
.
Walne A, Vulliamy T, Marrone A, Dokal I
(
2005
)
.
Genome Wide Linkage Analysis Suggests Genetic Heterogeneity in Autosomal Recessive Dyskeratosis Congenita, with One Locus on Chromosome 15
.
Blood
vol.
106
,
(
11
)
Walne A, Vulliamy T, Marrone A, Dokal I
(
2005
)
.
Genome wide linkage analysis suggests genetic heterogeneity in autosomal recessive dyskeratosis congenita, with one locus on chromosome 15
.
BLOOD
.
vol.
106
,
307A
-
308A
.
Vulliamy T, Beutler E, Luzzatto L
(
2005
)
.
Variants of glucose‐6‐phosphate dehydrogenase are due to missense mutations spread throughout the coding region of the gene
.
Human Mutation
vol.
2
,
(
3
)
159
-
167
.
Brito-Babapulle F, Hassan SH, Higgins C, Mcnally J, Naik R, Vulliamy T
(
2005
)
.
Eosinophilic fasciitis: The association with an underlying haematological disorder
.
BRITISH JOURNAL OF HAEMATOLOGY
.
vol.
129
,
52
-
52
.
MASON PJ, VULLIAMY TJ, FOULKES NS, Margaret T, HAIDAR B, LUZZATTO L
(
2005
)
.
The production of normal and variant human glucose‐6‐phosphate dehydrogenase in cos cells
.
The FEBS Journal
vol.
178
,
(
1
)
109
-
113
.
Lim F, Vulliamy T, Abdalla SH
(
2005
)
.
An Ashkenazi Jewish woman presenting with favism
.
J Clin Pathol
vol.
58
,
(
3
)
317
-
319
.
Barišić M, Korać J, Pavlinac I, Krželj V, Marušić E, Vulliamy T, Terzić J
(
2005
)
.
Characterization of G6PD deficiency in southern Croatia: description of a new variant, G6PD Split
.
J Hum Genet
vol.
50
,
(
11
)
547
-
549
.
Vulliamy TJ, Walne A, Baskaradas A, Mason PJ, Marrone A, Dokal I
(
2005
)
.
Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure
.
Blood Cells Mol Dis
vol.
34
,
(
3
)
257
-
263
.
Repiso A, Corrons JLV, Vulliamy T, Killeen N, Layton M, Carreras J, Climent F
(
2005
)
.
New haplotype for the Glu104Asp mutation in triose-phosphate isomerase deficiency and prenatal diagnosis in a Spanish family
.
J Inherit Metab Dis
vol.
28
,
(
5
)
807
-
809
.
Marrone A, Stevens D, Vulliamy T, Dokal I, Mason PJ
(
2004
)
.
Heterozygous telomerase RNA mutations found in dyskeratosis congenita and aplastic anemia reduce telomerase activity via haploinsufficiency
.
Blood
vol.
104
,
(
13
)
3936
-
3942
.
Benke S, Houston DS, Dokal I, Vulliamy T
(
2004
)
.
A novel hTERC deletion, manifesting with features of dyskeratosis congenita and genetic anticipation
.
BLOOD
.
vol.
104
,
126B
-
126B
.
Vulliamy TJ, Marrone A, Walne A, Stevens D, Mason PJ, Dokal IS
(
2004
)
.
The genetic and phenotypic diversity of dyskeratosis congenita
.
BLOOD
.
vol.
104
,
52A
-
53A
.
de la Fuente J, Reiss S, McCloy M, Vulliamy T, Roberts IAG, Rahemtulla A, Dokal I
(
2004
)
.
Erratum: Non-TBI stem cell transplantation protocol for Fanconi anaemia using HLA-compatible sibling and unrelated donors (Bone Marrow Transplantation (2003) vol. 32 (653-656) 10.1038/sj.bmt.1704219)
.
Bone Marrow Transplantation
vol.
34
,
(
1
)
de la Fuente J, Reiss S, McCloy M, Vulliamy T, Roberts IAG, Rahemtulla A, Dokal I
(
2004
)
.
Non-TBI stem cell transplantation protocol for Fanconi anaemia using HLA-compatible sibling and unrelated donors (vol 32, pg 653, 2003)
.
BONE MARROW TRANSPL
vol.
34
,
(
1
)
95
-
95
.
Keith WN, Vulliamy T, Zhao J, Ar C, Erzik C, Bilsland A, Ulku B, Marrone A et al.
(
2004
)
.
A mutation in a functional Sp1 binding site of the telomerase RNA gene (hTERC) promoter in a patient with Paroxysmal Nocturnal Haemoglobinuria
.
BMC Blood Disord
vol.
4
,
(
1
)
Vulliamy T, Marrone A, Szydlo R, Walne A, Mason PJ, Dokal I
(
2004
)
.
Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC
.
Nat Genet
vol.
36
,
(
5
)
447
-
449
.
Avery S, Nadal E, Marin D, Olavarria E, Kaeda J, Vulliamy T, Brito Babapulle F, Goldman JM et al.
(
2004
)
.
Lymphoid transformation in a CML patient in complete cytogenetic remission following treatment with imatinib
.
Leuk Res
vol.
28 Suppl 1
,
S75
-
S77
.
Brito-Babapulle F, Vulliamy T, Habboush HW, Higley K, Baxter J, Cross NCP
(
2004
)
.
Mechanism of eosinophilia in 26 cases of persistent unexplained eosinophilia. Low incidence of FIP1L1-PDGFRA, TEL-PDGFRB and rare variant BCR ABL
.
BRITISH JOURNAL OF HAEMATOLOGY
.
vol.
125
,
18
-
18
.
Tipping AJ, Vulliamy TJ, Morgan NV, Dokal I
(
2004
)
.
Molecular diagnosis of Fanconi anemia and dyskeratosis congenita
.
Methods Mol Med
vol.
91
,
3
-
17
.
Dokal I, Vulliamy T
(
2003
)
.
Dyskeratosis congenita: its link to telomerase and aplastic anaemia
.
Blood Rev
vol.
17
,
(
4
)
217
-
225
.
Sznajer Y, Baumann C, David A, Journel H, Lacombe D, Perel Y, Blouin P, Segura J-F et al.
(
2003
)
.
Further delineation of the congenital form of X-linked dyskeratosis congenita (Hoyeraal-Hreidarsson syndrome)
.
Eur J Pediatr
vol.
162
,
(
12
)
863
-
867
.
Vulliamy T, Marrone A, Szydlo R, Mason PJ, Dokal I
(
2003
)
.
Dyskeratosis congenita: Investigation of the relationship between telomere length and clinical severity and evidence of anticipation associated with progressive telomere shortening
.
BLOOD
.
vol.
102
,
158A
-
158A
.
Marrone A, Vulliamy T, Dokal I, Mason PJ
(
2003
)
.
Human telomerase RNA (hTERC) mutations found in dyskeratosis congenita and aplastic anemia affect telomerase activity by different mechanisms
.
BLOOD
.
vol.
102
,
158A
-
158A
.
Scopes DA, Bautista JM, Vulliamy TJ, Mason PJ
(
2003
)
.
Plasmodium falciparum glucose‐6‐phosphate dehydrogenase (G6PD) — the N‐terminal portion is homologous to a predicted protein encoded near to G6PD in Haemophilus influenzae
.
Molecular Microbiology
vol.
23
,
(
4
)
847
-
848
.
de la Fuente J, Reiss S, McCloy M, Vulliamy T, Roberts IAG, Rahemtulla A, Dokal I
(
2003
)
.
Non-TBI stem cell transplantation protocol for Fanconi anaemia using HLA-compatible sibling and unrelated donors
.
Bone Marrow Transplant
vol.
32
,
(
7
)
653
-
656
.
Sodeinde O, Clarke JL, Vulliamy TJ, Luzzatto L, Mason PJ
(
2003
)
.
Expression of Plasmodium falciparum G6PD-6PGL in laboratory parasites and in patient isolates in G6PD-deficient and normal Nigerian children
.
Br J Haematol
vol.
122
,
(
4
)
662
-
668
.
Knoblauch H, Tennstedt C, Brueck W, Hammer H, Vulliamy T, Dokal I, Lehmann R, Hanefeld F et al.
(
2003
)
.
Two brothers with findings resembling congenital intrauterine infection-like syndrome (pseudo-TORCH syndrome)
.
Am J Med Genet A
vol.
120A
,
(
2
)
261
-
265
.
Goldman F, Alsultan A, Thompson A, Vulliamy T, Marrone A, Mason P, Dokal I
(
2003
)
.
Humoral immune abnormalities in autosomal dominant Dyskeratosis Congenita
.
EXPERIMENTAL HEMATOLOGY
.
vol.
31
,
72
-
72
.
Clarke JL, Vulliamy TJ, Roper D, Mesbah-Namin SA, Wild BJ, Walker JI, Will AM, Bolton-Maggs PH et al.
(
2003
)
.
Combined glucose-6-phosphate dehydrogenase and glucosephosphate isomerase deficiency can alter clinical outcome
.
Blood Cells Mol Dis
vol.
30
,
(
3
)
258
-
263
.
Cossu F, Vulliamy TJ, Marrone A, Badiali M, Cao A, Dokal I
(
2002
)
.
A novel DKC1 mutation, severe combined immunodeficiency (T+B-NK- SCID) and bone marrow transplantation in an infant with Hoyeraal-Hreidarsson syndrome
.
Br J Haematol
vol.
119
,
(
3
)
765
-
768
.
He J, Navarrete S, Jasinski M, Vulliamy T, Dokal I, Bessler M, Mason PJ
(
2002
)
.
Targeted disruption of Dkc1, the gene mutated in X-linked dyskeratosis congenita, causes embryonic lethality in mice
.
Oncogene
vol.
21
,
(
50
)
7740
-
7744
.
Sznajer Y, Baumann C, Mechinaud F, David A, Journel H, Genevive D, Raoul M, Dumont M et al.
(
2002
)
.
Hoyeraal-Hreidarsson (HH) syndrome in three children
.
AMERICAN JOURNAL OF HUMAN GENETICS
.
vol.
71
,
284
-
284
.
Vulliamy T, Marrone A, Dokal I, Mason PJ
(
2002
)
.
Association between aplastic anaemia and mutations in telomerase RNA
.
Lancet
vol.
359
,
(
9324
)
2168
-
2170
.
Mesbah-Namin SA, Sanati MH, Mowjoodi A, Mason PJ, Vulliamy TJ, Noori-Daloii MR
(
2002
)
.
Three major glucose-6-phosphate dehydrogenase-deficient polymorphic variants identified in Mazandaran state of Iran
.
Br J Haematol
vol.
117
,
(
3
)
763
-
764
.
Knight S, Vulliamy T, Copplestone A, Gluckman E, Mason P, Dokal I
(
2002
)
.
Dyskeratosis Congenita (DC) Registry: identification of new features of DC
.
British Journal of Haematology
vol.
103
,
(
4
)
990
-
996
.
Beutler E, Vulliamy TJ
(
2002
)
.
Hematologically important mutations: glucose-6-phosphate dehydrogenase
.
Blood Cells Mol Dis
vol.
28
,
(
2
)
93
-
103
.
Vulliamy TJ, Kaeda JS, Ait‐Chafa D, Mangerini R, Roper D, Barbot J, Mehta AB, Athanassiou‐Metaxa et al.
(
2001
)
.
Clinical and haematological consequences of recurrent G6PD mutations and a single new mutation causing chronic nonspherocytic haemolytic anaemia
.
British Journal of Haematology
vol.
101
,
(
4
)
670
-
675
.
Kotea R, Kaeda JS, Yan SLK, Fa NS, Beesoon S, Jankee S, Ramasawmy R, Vulliamy T et al.
(
2001
)
.
Three major G6PD‐deficient polymorphic variants identified among the Mauritian population
.
British Journal of Haematology
vol.
104
,
(
4
)
849
-
854
.
Knight SW, Heiss NS, Vulliamy TJ, Aalfs CM, McMahon C, Richmond P, Jones A, Hennekam RCM et al.
(
2001
)
.
Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal‐Hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, DKC1
.
British Journal of Haematology
vol.
107
,
(
2
)
335
-
339
.
Mason PJ, Vulliamy T, Marrone A, Goldman F, Bessler M, Dokal I
(
2001
)
.
Autosomal dominant dyskeratosis congenita due to telomerase RNA defects: A novel mechanism of anticipation?
.
BLOOD
vol.
98
,
(
11
)
748A
-
748A
.
Vulliamy T, Marrone A, Goldman F, Dearlove A, Bessler M, Mason PJ, Dokal I
(
2001
)
.
The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita
.
Nature
vol.
413
,
(
6854
)
432
-
435
.
Amrolia PJ, Vulliamy T, Vassiliou G, Lawson S, Bryon J, Kaeda J, Dokal I, Johnston R et al.
(
2001
)
.
Analysis of chimaerism in thalassaemic children undergoing stem cell transplantation
.
Br J Haematol
vol.
114
,
(
1
)
219
-
225
.
Knight SW, Vulliamy TJ, Morgan B, Devriendt K, Mason PJ, Dokal I
(
2001
)
.
Identification of novel DKC1 mutations in patients with dyskeratosis congenita: implications for pathophysiology and diagnosis
.
Hum Genet
vol.
108
,
(
4
)
299
-
303
.
Vulliamy TJ, Knight SW, Mason PJ, Dokal I
(
2001
)
.
Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita
.
BLOOD CELL MOL DIS
vol.
27
,
(
2
)
353
-
357
.
McCloy M, Almeida A, Daly P, Vulliamy T, Roberts IA, Dokal I
(
2001
)
.
Fludarabine-based stem cell transplantation protocol for Fanconi's anaemia in myelodysplastic transformation
.
Br J Haematol
vol.
112
,
(
2
)
427
-
429
.
Vulliamy TJ, Knight SW, Mason PJ, Dokal I
(
2001
)
.
Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita
.
Blood Cells Mol Dis
vol.
27
,
(
2
)
353
-
357
.
Vulliamy T, Knight S, Mason P, Dokal I
(
2000
)
.
Very short telomeres but normal telomerase activity in patients with X-linked and autosomal dyskeratosis congenita
.
Blood
vol.
96
,
(
11 PART I
)
Olavarria E, Boecklin E, Rezvani K, Vulliamy T, Zaiac M, Parker S, Chase A, Mulvanny M et al.
(
2000
)
.
STI-571 induces mixed chimerism in patients relapsing in blastic transformation after allogeneic stem cell transplantation for chronic myeloid leukemia
.
BLOOD
vol.
96
,
(
11
)
471A
-
471A
.
Vulliamy T, Knight S, Mason P, Dokal I
(
2000
)
.
The ALA353VAL mutation in dyskerin accounts for similar to 40% of X-linked Dyskeratosis congenita and is associated with highly variable phenotypes
.
BLOOD
vol.
96
,
(
11
)
527A
-
527A
.
Vulliamy T, Knight S, Mason P, Dokal I
(
2000
)
.
Very short telomeres but normal telomerase activity in patients with X-linked and autosomal dyskeratosis congenita
.
BLOOD
vol.
96
,
(
11
)
4A
-
4A
.
Mehta A, Mason PJ, Vulliamy TJ
(
2000
)
.
Glucose-6-phosphate dehydrogenase deficiency
.
Best Practice & Research Clinical Haematology
vol.
13
,
(
1
)
21
-
38
.
Roos D, van Zwieten R, Wijnen JT, Gómez-Gallego F, de Boer M, Stevens D, Pronk-Admiraal CJ, de Rijk T et al.
(
1999
)
.
Molecular basis and enzymatic properties of glucose 6-phosphate dehydrogenase volendam, leading to chronic nonspherocytic anemia, granulocyte dysfunction, and increased susceptibility to infections
.
Blood
vol.
94
,
(
9
)
2955
-
2962
.
Vulliamy TJ, Knight SW, Heiss NS, Smith OP, Poustka A, Dokal I, Mason PJ
(
1999
)
.
Dyskeratosis congenita caused by a 3' deletion: germline and somatic mosaicism in a female carrier
.
Blood
vol.
94
,
(
4
)
1254
-
1260
.
Knight SW, Heiss NS, Vulliamy TJ, Greschner S, Stavrides G, Pai GS, Lestringant G, Varma N et al.
(
1999
)
.
X-Linked Dyskeratosis Congenita Is Predominantly Caused by Missense Mutations in the DKC1 Gene
.
American Journal of Human Genetics
vol.
65
,
(
1
)
50
-
58
.
Mason PJ, Stevens D, Diez A, Knight SW, Scopes DA, Vulliamy TJ
(
1999
)
.
Human Hexose-6-phosphate Dehydrogenase (Glucose 1-Dehydrogenase) Encoded at 1p36: Coding Sequence and Expression
.
Blood Cells Molecules and Diseases
vol.
25
,
(
1
)
30
-
37
.
Vulliamy T, Rovira A, Yusoff N, Colomer D, Luzzatto L, Vives‐Corrons J
(
1999
)
.
Independent origin of single and double mutations in the human glucose 6‐phosphate dehydrogenase gene
.
Human Mutation
vol.
8
,
(
4
)
311
-
318
.
Knight SW, Vulliamy TJ, Heiss NS, Matthijs G, Devriendt K, Connor JM, D'Urso M, Poustka A et al.
(
1998
)
.
1.4 Mb candidate gene region for X linked dyskeratosis congenita defined by combined haplotype and X chromosome inactivation analysis
.
Journal of Medical Genetics
vol.
35
,
(
12
)
Heiss NS, Knight SW, Vulliamy TJ, Klauck SM, Wiemann S, Mason PJ, Poustka A, Dokal I
(
1998
)
.
X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions
.
Nature Genetics
vol.
19
,
(
1
)
32
-
38
.
Mumford AD, Vulliamy T, Lindsay J, Watson A
(
1998
)
.
Hereditary hyperferritinemia-cataract syndrome: two novel mutations in the L-ferritin iron-responsive element
.
Blood
vol.
91
,
(
1
)
367
-
368
.
Vulliamy TJ, Knight SW, Dokal I, Mason PJ
(
1997
)
.
Skewed X-inactivation in carriers of X-linked dyskeratosis congenita
.
Blood
vol.
90
,
(
6
)
2213
-
2216
.
Vulliamy T, Luzzatto L, Hirono A, Beutler E
(
1997
)
.
Hematologically Important Mutations: Glucose-6-Phosphate Dehydrogenase
.
Blood Cells Molecules and Diseases
vol.
23
,
(
2
)
302
-
313
.
Spencer A, Vulliamy T, Kaeda J, Goldman J, Melo J
(
1997
)
.
Clonal instability preceding lymphoid blastic transformation of chronic myeloid leukemia
.
Leukemia
vol.
11
,
(
2
)
195
-
201
.
Baklouti F, Huang S-C, Vulliamy TJ, Delaunay J, Benz EJ
(
1997
)
.
Organization of the Human Protein 4.1 Genomic Locus: New Insights into the Tissue-Specific Alternative Splicing of the Pre-mRNA
.
Genomics
vol.
39
,
(
3
)
289
-
302
.
Knight SW, Vulliamy T, Forni GL, Oscier D, Mason PJ, Dokal I
(
1996
)
.
Fine mapping of the dyskeratosis congenita locus in Xq28
.
Journal of Medical Genetics
vol.
33
,
(
12
)
O'Rourke N, Kelly S, Vulliamy T, Price P
(
1996
)
.
Primary Ki-1 lymphoma and the aetiology of B symptoms
.
European Journal of Cancer
vol.
32
,
(
5
)
902
-
903
.
Konstantopoulos K, Vulliamy T, Swirsky D, Reeves JD, Kaeda J, Luzzatto L
(
1996
)
.
DNA haplotypes in Africans and West Indians with sickle cell anaemia or SC disease
.
Gene Geography
vol.
10
,
(
1
)
19
-
24
.
Naylor C, Rowland P, Basak A, Gover S, Mason P, Bautista J, Vulliamy T, Luzzatto L et al.
(
1996
)
.
Glucose 6-phosphate dehydrogenase mutations causing enzyme deficiency in a model of the tertiary structure of the human enzyme
.
Blood
vol.
87
,
(
7
)
2974
-
2982
.
Beutler E, Vulliamy T, Luzzatto L
(
1996
)
.
Hematologically Important Mutations: Glucose-6-phosphate Dehydrogenase
.
Blood Cells Molecules and Diseases
vol.
22
,
(
1
)
49
-
56
.
Nafa K, Bessler M, Mason P, Vulliamy T, Hillmen P, Castro-Malaspina H, Luzzatto L
(
1996
)
.
Factor V Leiden mutation investigated by amplification created restriction enzyme site (ACRES) in PNH patients with and without thrombosis
.
Haematologica
vol.
81
,
(
6
)
540
-
542
.
Kaeda JS, Chhotray GP, Ranjit MR, Bautista JM, Reddy PH, Stevens D, Naidu JM, Britt RP et al.
(
1995
)
.
A new glucose-6-phosphate dehydrogenase variant, G6PD Orissa (44 Ala-->Gly), is the major polymorphic variant in tribal populations in India
.
American Journal of Human Genetics
vol.
57
,
(
6
)
1335
-
1341
.
Spencer A, Vulliamy T, Chase A, Goldman JM
(
1995
)
.
Myeloid to lymphoid clonal succession following autologous transplantation in second chronic phase of chronic myeloid leukaemia
.
Leukemia
vol.
9
,
(
12
)
2138
-
2139
.
Srivastava P, Kaeda JS, Roper D, Vulliamy TJ, Buckley M, Luzzatto L
(
1995
)
.
Severe Hemolytic Anemia Associated With the Homozygous State for an Unstable Hemoglobin Variant (Hb Bushwick)
.
Blood
vol.
86
,
(
5
)
1977
-
1982
.
Mason PJ, Sonati MF, MacDonald D, Lanza C, Busutil D, Town M, Corcoran C, Kaeda JS et al.
(
1995
)
.
New Glucose-6-Phosphate Dehydrogenase Mutations Associated With Chronic Anemia
.
Blood
vol.
85
,
(
5
)
1377
-
1380
.
Ganczakowski M, Town M, Bowden DK, Vulliamy TJ, Kaneko A, Clegg JB, Weatherall DJ, Luzzatto L
(
1995
)
.
Multiple glucose 6-phosphate dehydrogenase-deficient variants correlate with malaria endemicity in the Vanuatu archipelago (southwestern Pacific)
.
American Journal of Human Genetics
vol.
56
,
(
1
)
294
-
301
.
Nafa K, Reghis A, Osmani N, Baghli L, Aït-Abbes H, Benabadji M, Kaplan J-C, Vulliamy T et al.
(
1994
)
.
At least five polymorphic mutants account for the prevalence of glucose-6-phosphate dehydrogenase deficiency in Algeria
.
Human Genetics
vol.
94
,
(
5
)
513
-
517
.
Rovlra A, Vulliamy TJ, Pujades A, Luzzatto L, Corrons J-LV
(
1994
)
.
The glucose-6-phosphate dehydrogenase (G6PD) deficient variant G6PD union (454 Arg→Cys) has a worldwide distribution possibly due to recurrent mutation
.
Human Molecular Genetics
vol.
3
,
(
5
)
833
-
835
.
O'Brien E, Kurdi-Haidar B, Wanachiwanawin W, Carvajal J-L, Vulliamy TJ, Cappadoro M, Mason PJ, Luzzatto L
(
1994
)
.
Cloning of the glucose 6-phosphate dehydrogenase gene from Plasmodium f alciparum
.
Molecular and Biochemical Parasitology
vol.
64
,
(
2
)
313
-
326
.
Sherratt TG, Vulliamy T, Dubowitz V, Sewry CA, Strong PN
(
1993
)
.
Exon skipping and translation in patients with frameshift deletions in the dystrophin gene
.
American Journal of Human Genetics
vol.
53
,
(
5
)
1007
-
1015
.
Filosa S, Calabrò V, Lania G, Vulliamy TJ, Brancati C, Tagarelli A, Luzzatto L, Martini G
(
1993
)
.
G6PD Haplotypes Spanning Xq28 from F8C to Red/Green Color Vision
.
Genomics
vol.
17
,
(
1
)
6
-
14
.
Oppenheim A, Jury CL, Rund D, Vulliamy TJ, Luzzatto L
(
1993
)
.
G6PD Mediterranean accounts for the high prevalence of G6PD deficiency in Kurdish Jews
.
Human Genetics
vol.
91
,
(
3
)
293
-
294
.
Nafa K, Reghis A, Osmani N, Baghli L, Benabadji M, Kaplan J-C, Vulliamy TJ, Luzzatto L
(
1993
)
.
G6PD Aures: a new mutation (48 lle → Thr) causing mild G6PD deficiency is associated with favism
.
Human Molecular Genetics
vol.
2
,
(
1
)
81
-
82
.
Sherratt TG, Vulliamy T, Strong PN
(
1992
)
.
Evolutionary conservation of the dystrophin central rod domain
.
Biochemical Journal
vol.
287
,
(
3
)
755
-
759
.
Ahluwalia A, Corcoran CM, Vulliamy TJ, Ishwad CS, Naidu JM, Argusti A, Stevens DJ, Mason PJ et al.
(
1992
)
.
G6PD Kalyan and G6PD Kerala; two deficient variants in India caused by the same 317 Glu↑Lys mutation
.
Human Molecular Genetics
vol.
1
,
(
3
)
209
-
210
.
Vulliamy T, Mason P, Luzzatto L
(
1992
)
.
The molecular basis of glucose-6-phosphate dehydrogenase deficiency
.
Trends in Genetics
vol.
8
,
(
4
)
138
-
143
.
Corcoran CM, Calabrò V, Tamagnini G, Town M, Haidar B, Vulliamy TJ, Mason PJ, Luzzatto L
(
1992
)
.
Molecular heterogeneity underlying the G6PD Mediterranean phenotype
.
Human Genetics
vol.
88
,
(
6
)
688
-
690
.
FRANKEL AH, THOMPSON M, VULLIAMY T, WILLIAMS G, THOMAS JA, CRAWFORD DH, REES AJ, LECHLER R
(
1991
)
.
A T CELL CLONE IN ASSOCIATION WITH AN EPSTEIN-BARR VIRUS-RELATED B CELL LYMPHOMA
.
Transplantation
vol.
52
,
(
6
)
Vulliamy TJ, Othman A, Town M, Nathwani A, Falusi AG, Mason PJ, Luzzatto L
(
1991
)
.
Polymorphic sites in the African population detected by sequence analysis of the glucose-6-phosphate dehydrogenase gene outline the evolution of the variants A and A-
.
Proceedings of the National Academy of Sciences of the United States of America
vol.
88
,
(
19
)
8568
-
8571
.
Macdonald D, Town M, Mason P, Vulliamy T, Luzzatto L, Goff DK
(
1991
)
.
Deficiency in red blood cells
.
Nature
vol.
350
,
(
6314
)
115
-
115
.
Vulliamy TJ, Othman A, Town M, Nathwani A, Falusi Y, Luzzatto L
(
1991
)
.
Linkage disequilibrium of polymorphic sites in the G6PD gene in African populations and the origin of G6PD A-
.
Gene Geography
vol.
5
,
(
1-2
)
13
-
21
.
Mason PJ, Bautista J, Vulliamy TJ, Turner N, Luzzatto L
(
1990
)
.
Human red cell glucose-6-phosphate dehydrogenase is encoded only on the X chromosome
.
Cell
vol.
62
,
(
1
)
9
-
10
.
Fey MF, Wainscoat JS, Mukwala EC, Falusi AG, Vulliamy TJ, Luzzatto L
(
1990
)
.
A PvuII restriction fragment length polymorphism of the glucose-6-phosphate dehydrogenase gene is an African-specific marker
.
Human Genetics
vol.
84
,
(
5
)
471
-
472
.
Stevens DJ, Wanachiwanawin W, Mason PJ, Vulliamy TJ, Luzzatto L
(
1990
)
.
G6PD Canton a common deficient variant in South East Asia caused by a 459 Arg→Leu mutation
.
Nucleic Acids Research
vol.
18
,
(
23
)
7190
-
7190
.
Vulliamy TJ, Wanachiwanawin W, Mason PJ, Luzzatto L
(
1989
)
.
G6PD Mahidol, a common deficient variant in South East Asia is caused by a (163)g;ycine - serine mutation
.
Nucleic Acids Research
vol.
17
,
(
14
)
5868
-
5868
.
Vulliamy TJ, D'Urso M, Battistuzzi G, Estrada M, Foulkes NS, Martini G, Calabro V, Poggi V et al.
(
1988
)
.
Diverse point mutations in the human glucose-6-phosphate dehydrogenase gene cause enzyme deficiency and mild or severe hemolytic anemia
.
Proceedings of the National Academy of Sciences of the United States of America
vol.
85
,
(
14
)
5171
-
5175
.
D'Urso M, Luzzatto L, Perroni L, Ciccodicola A, Gentile G, Peluso I, Persico MG, Pizzella T et al.
(
1988
)
.
An extensive search for RFLP in the human glucose-6-phosphate dehydrogenase locus has revealed a silent mutation in the coding sequence
.
American Journal of Human Genetics
vol.
42
,
(
5
)
735
-
741
.
Persico MG, Viglietto G, Martini G, Toniolo D, Paonessa G, Moscatelli C, Dono R, Vulliamy T et al.
(
1986
)
.
Isolation of human glucose-6-phosphate dehydrogenase (G6PD) cDNA clones: primary structure of the protein and unusual 5′ non-coding region
.
Nucleic Acids Research
vol.
14
,
(
19
)
7821
-
7821
.
Martini G, Toniolo D, Vulliamy T, Luzzatto L, Dono R, Viglietto G, Paonessa G, D'Urso M et al.
(
1986
)
.
Structural analysis of the X‐linked gene encoding human glucose 6‐phosphate dehydrogenase
.
The EMBO Journal
vol.
5
,
(
8
)
1849
-
1855
.
Persico MG, Viglietto G, Martini G, Toniolo D, Paonessa G, Moscatelli C, Dono R, Vulliamy T et al.
(
1986
)
.
Isolation of human glucose-6-pbosphate debydrogenase (G6PD) cDNA clones: primary structure of the protein and unusual 5' non-coding region
.
Nucleic Acids Research
vol.
14
,
(
6
)
2511
-
2522
.